BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic MelanomaDennie T. Frederick, Jennifer A. Wargo, Keith T. Flaherty et al.|Clinical Cancer Research|2013Cited by 938
The COX2 Effector Microsomal PGE2 Synthase 1 is a Regulator of Immunosuppression in Cutaneous MelanomaSun-Hee Kim, Elizabeth A. Grimm, Jason Roszik et al.|Clinical Cancer Research|2018Cited by 55
Integrating genome-wide CRISPR immune screen with multi-omic clinical data reveals distinct classes of tumor intrinsic immune regulatorsJiakai Hou, Weiyi Peng|Journal for ImmunoTherapy of Cancer|2021Cited by 47
Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune ResponsesAndrew Fedoriw, Weiyi Peng|Cancer Immunology Research|2022Cited by 31
MTA-cooperative PRMT5 inhibitors enhance T cell-mediated antitumor activity in MTAP-loss tumorsSi Chen, Weiyi Peng|Journal for ImmunoTherapy of Cancer|2024Cited by 18